A trial fibrillation and embolic stroke are frequent and potentially grave complications of the sick sinus syndrome.' Single-chamber ventricular pacing is efficacious in preventing bradycardia-related symptoms in patients with sick sinus syndrome,2'3 but it may not decrease morbidity from atrial fibrillation and stroke.4 Although no differences in long-term survival between ventricular pacing and physiological pacing have been demonstrated,5 atrial and dual-chamber pacemakers may be more efficient than ventricular pacemakers in improving quality of life and exercise tolerances and in reducing morbid event rates.7 However, no randomized study or multivariate analysis of a large retrospective cohort has addressed this issue. As sick sinus syndrome is the most frequent indication for permanent pacing, the investigation of the optimal pacing mode for these patients is important both clinically and economically.8
To address the impact of different pacing modalities on the incidence of chronic atrial fibrillation and stroke, we studied 507 consecutive patients who had an initial pacemaker implant for sick sinus syndrome.
Methods

Study Patients
We retrospectively analyzed all 507 adult patients (age of more than 18 years) with isolated sick sinus syndrome who received an initial pacemaker between January 1, 1980, and December 31, 1989 . Sick sinus syndrome was defined by the presence of inappropriate, persistent sinus bradycardia (rate of less than 50 beats per minute), sinus pauses longer than 3 seconds, or sinoatrial block. Patients with established atrial fibrillation or with concomitant complete atrioventricular block or type II second-degree atrioventricular block at time of implant were excluded from the study. All patients were symptomatic, required bradycardia-producing drugs for treatment of tachyarrhythmias, or both.
Baseline variables describing cardiac disease, concomitant diseases, and ECG and echocardiographic findings were analyzed ( (43) 173 (44) 44 (39) NS Valvular heart disease 61 (12) 45 (11) 16 (14) NS Cardiomyopathy 35 (7) 29 (7) 6(5) NS Othert 46 (9) 40 (10) 6(5) NS Concomitant diseases (n, %) Hypertension 217 (43) 161 (41) 56 (50) NS Diabetes 72 (14) 54 (14) 18(16) NS Cerebrovascular disease 101 (20) 69 (17) 32 (29) .01 Peripheral vascular disease 45 (9) 29 (7) 16 (14) .03 Electrocardiographic findings (n, %)
Bundle branch block 77 (15) 59 (15) 18 (17) (CAF) and stroke (n=507). Fib indicates fibrillation. compliance for drug therapy would limit the postdischarge predictive value of these variables.
Results
Chronic Atrial Fibrillation
For the end point "chronic atrial fibrillation," patients were followed for a maximum of 134 months (mean: 59±38 months), and 88 patients (17%) developed chronic atrial fibrillation. Actuarial incidence of chronic atrial fibrillation was 7% at 1 year, 16% at 5 years, and 28% at 10 years (Fig 1) . Univariate predictors for atrial fibrillation were a prior history of paroxysmal atrial fibrillation (P<.001) (Fig 2) , history of paroxysmal atrial fibrillation for more than 5 years (P<.001) (Fig 3) , prolonged episodes of paroxysmal atrial fibrillation (more than 1 hour) (P<.001) (Fig 4) , valvular heart disease (P<.001), use of preimplant antiarrhythmic drugs (P<.001), left atrial enlargement (P<.001), discharge on antiarrhythmic drugs (P<.005), DC cardioversion (P=.005), age (P=.002), and ventricular pacing mode (P=.01) (Fig 5) . The variable "left ventricular dysfunction" did not reach statistical significance in the subgroup of patients for whom this information was available. Interestingly, the incidence of chronic atrial fibrillation was 0% during the first 5 years of follow-up for patients without a history of paroxysmal atrial fibrillation, for both pacing modalities (Fig 2) . In the absence of randomized trials, the impact of different pacing modalities on the development of chronic atrial fibrillation in patients with the sick sinus syndrome is difficult to determine. Previous studies have suggested that single-chamber ventricular pacing has a strong influence on the incidence of chronic atrial fibrillation and stroke.25-3' However, most of those studies lack methodological rigorousness and thus are subject to bias, such as may occur with incomplete follow-up mainly restricted to patients who regularly check their pacemakers at a particular hospital.27 Noncontemporary cohorts are another source of bias, as when ventricularly paced patients enter years earlier into retrospective studies28,29 and thus undergo longer follow-up periods than physiologically paced patients. 30 
Role of Pacing Mode in the Development ofAtrial Fibrillation
The exact mechanisms associating VVI pacing and the development of chronic atrial fibrillation in sick sinus syndrome are far from being understood. Singlechamber ventricular pacing may predispose to chronic atrial fibrillation, or, as an alternative, pacing in the atrium may prevent or delay the natural evolution of sick sinus syndrome to chronic atrial fibrillation. It has been suggested that loss of atrioventricular synchrony perpetuated by ventriculoatrial conduction -observed in ventricularly paced patients -leads to progressive increases in left atrial pressure and consequently to left atrial enlargement,35 thus predisposing to atrial fibrillation.36 However, prospective studies in patients with baseline normal atria have showed that atrial enlargement is a consequence of atrial fibrillation rather than its predisposing factor.37,38 Furthermore, if the adverse hemodynamic effects associated with atrioventricular asynchrony were the cause for chronic atrial fibrillation, it is not clear why our patients with ventricular pacemakers and without preimplant paroxysmal atrial fibrillation did not develop chronic atrial fibrillation as well. Another theory is that ventriculoatrial conduction predisposes to atrial fibrillation by modifying atrial refractoriness. 4 However, in patients without structural heart disease, the atrial refractory periods do not appear to change with extreme alterations in the atrioventricular interval, nor is inducibility of atrial fibrillation different.39 Although these findings need to be confirmed in larger populations, they are helpful in explaining why ventricular pacing did not predispose our patients without preimplant paroxysmal atrial fibrillation to chronic atrial fibrillation. It seems that ventricular pacing may allow progression of paroxysmal atrial fibrillation into the chronic arrhythmia, rather than creating a new milieu leading to atrial fibrillation. Precise understanding of the mechanisms involved in the association between atrial fibrillation and ventricular pacing (if such an association is confirmed in a randomized study) may require complex computer-simulated models of sinoatrial nodal and atrial networks40,4 capable of reliably reproducing the true interactions between chronic ventricular pacing and the human sick sinus node.
It has been hypothesized that atrial pacing prevents paroxysmal atrial fibrillation from evolving to chronicity by eliminating sinus bradycardia with concomitant homogenization of atrial refractory periods. However, Luck and Engel18 found that patients with sick sinus syndrome vulnerable to atrial fibrillation did not consistently show increased dispersion of refractoriness and that abnormal refractoriness did not improve by eliminating bradycardia with atrial pacing, suggesting that in humans the role of heart rate as a determinant of dispersion of atrial refractoriness is negligible. Thus, it is more likely that the beneficial effect of atrial pacing resides in preventing reinitiation of the arrhythmia (once sinus rhythm is restored) by maintaining a high degree of exit block from all natural subsidiary atrial pacemakers.42 '43 However, this antiarrhythmic effect should also be provided by retrograde ventriculoatrial conduction during VVI pacing. Nonetheless, only a "proarrhythmic" effect has been classically attributed to ventriculoatrial conduction in VVI pacing. Clearcut electrophysiological information simply is not available to completely explain the clinical benefit of atrial pacing in avoiding chronic atrial fibrillation, and further studies are needed.
Stroke
As in unpaced populations, stroke was predicted by history of cerebrovascular disease44 and history of paroxysmal atrial fibrillation.45 It is noteworthy that ventricular pacing mode remained an independent predictor for stroke after adjusting for paroxysmal atrial fibrillation. A statistically significant higher proportion of patients in the VVI group had history of cerebrovascular disease. Therefore, although ventricular pacing remained an independent predictor for stroke in the multivariate analysis, it cannot be ruled out that it may have acted as a surrogate for an unmeasured variable associated with stroke.
Role of Pacing Mode on Development of Stroke
In addition to the presence of atrial fibrillation as the mechanism linking ventricular pacing with embolic stroke, other factors must be involved in this association, because stroke was predicted by VVI pacing independent of atrial fibrillation. Alternative mechanisms may include the existence of ventriculoatrial conduction in the absence of atrial fibrillation,46 subclin-ical "atrial hypervulnerability,"47 and short-lived, occult episodes of paroxysmal atrial fibrillation.48 Left ventricular dysfunction was not a risk factor for stroke in our population; left ventricular ejection fraction has been reported to remain stable with VVI pacing. 49 It is unlikely that undocumented reductions in cardiac output resulting from VVI pacing can decrease carotid flow to the point of ischemia and thrombotic stroke. It should be noted that the relation between pacing mode and stroke will be less clinically relevant in the future; a widespread use of aspirin and warfarin in patients with paroxysmal atrial fibrillation is likely to markedly decrease the number of thrombotic and embolic events, regardless of the pacing modality.
Study Limitations
The possibility that ventricular pacing mode is only a surrogate for undetected confounding variables cannot be excluded. Although multivariate analysis is the best tool to analyze retrospective studies, it can be used only to adjust for the known imbalances between patient groups50; the potential effects of hidden variables remain possible.
Comparison with "chronic" atrial fibrillation rates reported in other studies should be cautious. No standard definition of "chronic" atrial fibrillation exists; there is tacit agreement that atrial fibrillation is "chronic" when no further return to sinus rhythm takes place. However, that is a "retrospective" diagnosis. The actual presence or absence of the arrhythmia is not always apparent from symptoms, and vice versa, some symptoms may be falsely ascribed to atrial fibrillation.51 In patients who are not aware of their episodes, "paroxysmal" atrial fibrillation may be underdiagnosed, or the diagnosis of "chronic" atrial fibrillation may be delayed. Likewise, eventual unrecorded return to sinus rhythm after prolonged episodes of paroxysmal atrial fibrillation may lead to overdiagnosis of "chronic" atrial fibrillation. When sinus rhythm is restored and maintained after cardioversion for several months after sustained atrial fibrillation, a confusing status from the semiotic point of view arises. The ECG manifestation of a paced rhythm may add further limitations to the identification of the underlying rhythm during the follow-up, particularly in pacemaker-dependent patients.
These problems have led to the use of arbitrary definitions,7,21,52-54 which contributes to the wide interstudy variations regarding incidence of "chronic" atrial fibrillation in paced patients with sick sinus syndrome.725, 55 The definition for "paroxysmal" atrial fibrillation, instead, is more uniform. Yet, paroxysmal atrial fibrillation may be an unrecognized portion of a patient's past history. Thus, the number of hours of ambulatory and telemetry ECG recordings plays an essential role in characterizing the population a priori and in eliciting conclusions about the true incidence of "chronic" atrial fibrillation.
The relation between left atrial size and the development of chronic atrial fibrillation remains controversial.37 '38-56'57 Finally, the lack of precise information on the characteristics of the stroke events in our population raises the possibility of erroneously ascribing some of the cerebrovascular accidents to atrial fibrillation. At the same time, the low number of patients discharged on oral anticoagulation (mainly patients with previous stroke or mechanical valvular prosthesis) makes it difficult to extrapolate our data to current paced populations with sick sinus syndrome. An expected increased use of anticoagulants and antiplatelet agents in patients with paroxysmal atrial fibrillation will change the natural history in these populations, considerably limiting the stroke rates.
Need for a Randomized Study
Based on this and previous reports, the deleterious role of ventricular pacing modalities in development of atrial fibrillation is still not conclusive. It is noteworthy that dual-chamber pacing might not prevent the development of chronic atrial fibrillation in patients at greater risk (ie, with prolonged episodes or many years of paroxysmal atrial fibrillation). Hummel and colleagues58 and Gross and colleagues59 reported a relatively high incidence of loss of DDD pacing mode (15% and 18%, respectively) after much shorter follow-up periods than ours (mean: 30 and 33 months, respectively). An incomplete follow-up in the first study (only 61% patient records were available) raises the question of a higher true incidence of loss of atrial pacing in that population. Although these statistics include a few instances of reprogramming to VVI(R) mode because of atrial lead problems, their incidence of chronic atrial fibrillation was higher than ours. This is especially surprising because sick sinus syndrome was the less prevalent disease in their populations (45% and 38%), and all patients had dual-chamber pacemakers. Moreover, the existence of selection bias had been admitted by Gross and colleagues in a previous report60 as patients perceived as "inevitably" developing atrial fibrillation received a VVI pacemaker, eliminating the subgroup at the highest risk from the analysis.
A large, randomized study appears to be necessary to confirm the role of pacing modalities in the development of chronic atrial fibrillation.61 In our study, the incidence of this arrhythmia was extremely low for patients with no history of paroxysmal atrial fibrillation and did not appear to be influenced by the pacing modality during the first 10 years after implant. Thus, a randomized study probably should focus only on patients with preimplant paroxysmal atrial fibrillation. To increase the power of the study, a particular effort to enroll patients with "high-risk" paroxysmal atrial fibrillation (ie, with episodes lasting more than 1 hour or with a history of the arrhythmia for more than 5 years) should be made.62 This will allow the performance of a rigorous analysis of the cost-effectiveness and quality of life of dual-chamber versus single-chamber ventricular pacing modalities as physiologically paced patients with more persistent preimplant paroxysmal atrial fibrillation are the most likely to require reprogramming to a ventricular pacing mode. 63 
Conclusions and Clinical Implications
From the present retrospective study, it appears that morbid events in paced patients with sick sinus syn-drome are strongly predicted by clinical variables. Pacing mode appears to play a significant but less important role as a risk factor for chronic atrial fibrillation and stroke. Development of chronic atrial fibrillation is relatively frequent; almost 50% of total incidence occurs within the first 2 years after implant. However, patients without a history of paroxysmal atrial fibrillation are expected to remain free of chronic atrial fibrillation during the first 4 years after pacemaker implantation and to have a negligible incidence of this complication afterward regardless of pacing modality. Chronic atrial fibrillation is strongly predicted not only by history of paroxysmal atrial fibrillation but also by the characteristics quantifying its persistence; such variables have not been previously analyzed and could have acted as important confounding factors in previous reports. Ventricular pacing mode, age, and valvular heart disease are additional independent risk factors for chronic atrial fibrillation. Stroke is a less frequent complication, but it can be fatal. Unlike chronic atrial fibrillation, it is not an early event; most of the episodes occur after the fifth year of pacemaker implantation. Independent risk factors for stroke are history of cerebrovascular disease, ventricular pacing mode, and history of paroxysmal atrial fibrillation; consequently, it would be appropriate to chronically anticoagulate patients with any of these risk factors. Ventricular pacing remains the most frequently selected modality in the United States.M Considering the higher costs of dual-chamber devices, ventricular pacing should not be precluded in selected patients with sick sinus syndrome without paroxysmal atrial fibrillation because for these patients, the risk of chronic atrial fibrillation and stroke probably is negligible.
